Their invention, initial authorization and later approval signaled ... For now, HHS appears to be retreating primarily from ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

Raina Biosciences Inc. (Raina), an mRNA technology and therapeutics company, has released data from its generative AI platform in Science. The data supports Raina's pioneering approach to mRNA design ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

(The Hill) — Former U.S. Surgeon General Jerome Adams on Sunday pushed back against the Department of Health and Human Services (HHS) recently winding down its mRNA vaccine development activities via ...

Dr. Sarah Boyd, an infectious disease specialist with Saint Luke's Health System, told KCUR that federal cuts to mRNA research and development could cause a setback in pandemic preparedness. Last week ...

Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did ...

Messenger RNA technology, better known as mRNA technology, made it possible to rapidly deploy a new vaccine during the COVID-19 pandemic — much earlier than would otherwise have been possible, saving ...